{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0207","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0207","name":[{"text":"Dose 1 to dose 3 interval 16 weeks.  Series complete. \nEvaluation_Test_Type: Interval: At Minimum\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete."}],"gender":"female","birthDate":"2019-12-08"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0207-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"Hep B, adolescent or pediatric"}]},"patient":{"reference":"Patient/2013-0207"},"date":"2020-03-09T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0207-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"Hep B, adolescent or pediatric"}]},"patient":{"reference":"Patient/2013-0207"},"date":"2020-04-24T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0207-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"Hep B, adolescent or pediatric"}]},"patient":{"reference":"Patient/2013-0207"},"date":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}},{"resource":{"resourceType":"Parameters","parameter":[{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0207"},"recommendation":[{"date":"2020-06-29T00:00:00.000","forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2999-12-31T00:00:00.000"}],"protocol":{"description":"Evaluation_Test_Type: Interval: At Minimum\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete.","series":"HepB"}}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}